Global and China Lisinopril Market Insights, Forecast to 2027

Publisher Name :
Date: 29-Dec-2021
No. of pages: 165
Inquire Before Buying

Lisinopril market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lisinopril market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Lisinopril market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- 2.5mg

- 5mg

- 10mg

- 20mg

- 30mg

- 40mg

Segment by Application

- Hospital

- Drug Store

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Actavis Elizabeth

- Apotex

- Aurobindo Pharma

- Ivax Pharmaceuticals

- Lek Pharmaceuticals

- Lupin

- Mylan Pharmaceuticals

- Ranbaxy Pharmaceuticals

- Novartis

- Teva Pharmaceuticals

- Vintage Pharmaceuticals

- Watson Laboratories

- West Ward Pharmaceutical

- Wockhardt

- Merck Research Laboratories

- Astrazeneca

- Alvogen

- Hikma

- Prinston

- Accord Hlthcare

- CASI Pharms

- Invagen Pharms

- SUN Pharm

Global and China Lisinopril Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Lisinopril Product Introduction
1.2 Market by Type
1.2.1 Global Lisinopril Market Size Growth Rate by Type
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Market by Application
1.3.1 Global Lisinopril Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Lisinopril Market Size, Estimates and Forecasts
2.1.1 Global Lisinopril Revenue 2016-2027
2.1.2 Global Lisinopril Sales 2016-2027
2.2 Global Lisinopril, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Lisinopril Historical Market Size by Region (2016-2021)
2.3.1 Global Lisinopril Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Lisinopril Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Lisinopril Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Lisinopril Sales Forecast by Region (2022-2027)
2.4.2 Global Lisinopril Revenue Forecast by Region (2022-2027)
3 Global Lisinopril Competitor Landscape by Players
3.1 Global Top Lisinopril Manufacturers by Sales
3.1.1 Global Lisinopril Sales by Manufacturer (2016-2021)
3.1.2 Global Lisinopril Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Lisinopril Manufacturers by Revenue
3.2.1 Key Lisinopril Manufacturers Covered: Ranking by Revenue
3.2.2 Global Lisinopril Revenue by Manufacturers (2016-2021)
3.2.3 Global Lisinopril Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Lisinopril Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Lisinopril Revenue in 2020
3.2.6 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Lisinopril Price by Manufacturers
3.4 Global Lisinopril Manufacturing Base Distribution, Product Types
3.4.1 Lisinopril Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Lisinopril Product Type
3.4.3 Date of International Manufacturers Enter into Lisinopril Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Lisinopril Market Size by Type (2016-2021)
4.1.1 Global Lisinopril Sales by Type (2016-2021)
4.1.2 Global Lisinopril Revenue by Type (2016-2021)
4.1.3 Lisinopril Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Lisinopril Market Size Forecast by Type (2022-2027)
4.2.1 Global Lisinopril Sales Forecast by Type (2022-2027)
4.2.2 Global Lisinopril Revenue Forecast by Type (2022-2027)
4.2.3 Lisinopril Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Lisinopril Market Size by Application (2016-2021)
5.1.1 Global Lisinopril Sales by Application (2016-2021)
5.1.2 Global Lisinopril Revenue by Application (2016-2021)
5.1.3 Lisinopril Price by Application (2016-2021)
5.2 Lisinopril Market Size Forecast by Application (2022-2027)
5.2.1 Global Lisinopril Sales Forecast by Application (2022-2027)
5.2.2 Global Lisinopril Revenue Forecast by Application (2022-2027)
5.2.3 Global Lisinopril Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Lisinopril Market Size YoY Growth 2016-2027
6.1.1 China Lisinopril Sales YoY Growth 2016-2027
6.1.2 China Lisinopril Revenue YoY Growth 2016-2027
6.1.3 China Lisinopril Market Share in Global Market 2016-2027
6.2 China Lisinopril Market Size by Players (International and Local Players)
6.2.1 China Top Lisinopril Players by Sales (2016-2021)
6.2.2 China Top Lisinopril Players by Revenue (2016-2021)
6.3 China Lisinopril Historic Market Review by Type (2016-2021)
6.3.1 China Lisinopril Sales Market Share by Type (2016-2021)
6.3.2 China Lisinopril Revenue Market Share by Type (2016-2021)
6.3.3 China Lisinopril Price by Type (2016-2021)
6.4 China Lisinopril Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Lisinopril Sales Forecast by Type (2022-2027)
6.4.2 China Lisinopril Revenue Forecast by Type (2022-2027)
6.4.3 China Lisinopril Price Forecast by Type (2022-2027)
6.5 China Lisinopril Historic Market Review by Application (2016-2021)
6.5.1 China Lisinopril Sales Market Share by Application (2016-2021)
6.5.2 China Lisinopril Revenue Market Share by Application (2016-2021)
6.5.3 China Lisinopril Price by Application (2016-2021)
6.6 China Lisinopril Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Lisinopril Sales Forecast by Application (2022-2027)
6.6.2 China Lisinopril Revenue Forecast by Application (2022-2027)
6.6.3 China Lisinopril Price Forecast by Application (2022-2027)
7 North America
7.1 North America Lisinopril Market Size YoY Growth 2016-2027
7.2 North America Lisinopril Market Facts & Figures by Country
7.2.1 North America Lisinopril Sales by Country (2016-2021)
7.2.2 North America Lisinopril Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Lisinopril Market Size YoY Growth 2016-2027
8.2 Asia Pacific Lisinopril Market Facts & Figures by Region
8.2.1 Asia Pacific Lisinopril Sales by Region (2016-2021)
8.2.2 Asia Pacific Lisinopril Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Lisinopril Market Size YoY Growth 2016-2027
9.2 Europe Lisinopril Market Facts & Figures by Country
9.2.1 Europe Lisinopril Sales by Country (2016-2021)
9.2.2 Europe Lisinopril Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Lisinopril Market Size YoY Growth 2016-2027
10.2 Latin America Lisinopril Market Facts & Figures by Country
10.2.1 Latin America Lisinopril Sales by Country (2016-2021)
10.2.2 Latin America Lisinopril Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Lisinopril Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Lisinopril Market Facts & Figures by Country
11.2.1 Middle East and Africa Lisinopril Sales by Country (2016-2021)
11.2.2 Middle East and Africa Lisinopril Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Actavis Elizabeth
12.1.1 Actavis Elizabeth Corporation Information
12.1.2 Actavis Elizabeth Description and Business Overview
12.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Actavis Elizabeth Lisinopril Products Offered
12.1.5 Actavis Elizabeth Recent Development
12.2 Apotex
12.2.1 Apotex Corporation Information
12.2.2 Apotex Description and Business Overview
12.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Apotex Lisinopril Products Offered
12.2.5 Apotex Recent Development
12.3 Aurobindo Pharma
12.3.1 Aurobindo Pharma Corporation Information
12.3.2 Aurobindo Pharma Description and Business Overview
12.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Aurobindo Pharma Lisinopril Products Offered
12.3.5 Aurobindo Pharma Recent Development
12.4 Ivax Pharmaceuticals
12.4.1 Ivax Pharmaceuticals Corporation Information
12.4.2 Ivax Pharmaceuticals Description and Business Overview
12.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ivax Pharmaceuticals Lisinopril Products Offered
12.4.5 Ivax Pharmaceuticals Recent Development
12.5 Lek Pharmaceuticals
12.5.1 Lek Pharmaceuticals Corporation Information
12.5.2 Lek Pharmaceuticals Description and Business Overview
12.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lek Pharmaceuticals Lisinopril Products Offered
12.5.5 Lek Pharmaceuticals Recent Development
12.6 Lupin
12.6.1 Lupin Corporation Information
12.6.2 Lupin Description and Business Overview
12.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Lupin Lisinopril Products Offered
12.6.5 Lupin Recent Development
12.7 Mylan Pharmaceuticals
12.7.1 Mylan Pharmaceuticals Corporation Information
12.7.2 Mylan Pharmaceuticals Description and Business Overview
12.7.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mylan Pharmaceuticals Lisinopril Products Offered
12.7.5 Mylan Pharmaceuticals Recent Development
12.8 Ranbaxy Pharmaceuticals
12.8.1 Ranbaxy Pharmaceuticals Corporation Information
12.8.2 Ranbaxy Pharmaceuticals Description and Business Overview
12.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Ranbaxy Pharmaceuticals Lisinopril Products Offered
12.8.5 Ranbaxy Pharmaceuticals Recent Development
12.9 Novartis
12.9.1 Novartis Corporation Information
12.9.2 Novartis Description and Business Overview
12.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Novartis Lisinopril Products Offered
12.9.5 Novartis Recent Development
12.10 Teva Pharmaceuticals
12.10.1 Teva Pharmaceuticals Corporation Information
12.10.2 Teva Pharmaceuticals Description and Business Overview
12.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceuticals Lisinopril Products Offered
12.10.5 Teva Pharmaceuticals Recent Development
12.11 Actavis Elizabeth
12.11.1 Actavis Elizabeth Corporation Information
12.11.2 Actavis Elizabeth Description and Business Overview
12.11.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Actavis Elizabeth Lisinopril Products Offered
12.11.5 Actavis Elizabeth Recent Development
12.12 Watson Laboratories
12.12.1 Watson Laboratories Corporation Information
12.12.2 Watson Laboratories Description and Business Overview
12.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Watson Laboratories Products Offered
12.12.5 Watson Laboratories Recent Development
12.13 West Ward Pharmaceutical
12.13.1 West Ward Pharmaceutical Corporation Information
12.13.2 West Ward Pharmaceutical Description and Business Overview
12.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.13.4 West Ward Pharmaceutical Products Offered
12.13.5 West Ward Pharmaceutical Recent Development
12.14 Wockhardt
12.14.1 Wockhardt Corporation Information
12.14.2 Wockhardt Description and Business Overview
12.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Wockhardt Products Offered
12.14.5 Wockhardt Recent Development
12.15 Merck Research Laboratories
12.15.1 Merck Research Laboratories Corporation Information
12.15.2 Merck Research Laboratories Description and Business Overview
12.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Merck Research Laboratories Products Offered
12.15.5 Merck Research Laboratories Recent Development
12.16 Astrazeneca
12.16.1 Astrazeneca Corporation Information
12.16.2 Astrazeneca Description and Business Overview
12.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Astrazeneca Products Offered
12.16.5 Astrazeneca Recent Development
12.17 Alvogen
12.17.1 Alvogen Corporation Information
12.17.2 Alvogen Description and Business Overview
12.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Alvogen Products Offered
12.17.5 Alvogen Recent Development
12.18 Hikma
12.18.1 Hikma Corporation Information
12.18.2 Hikma Description and Business Overview
12.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Hikma Products Offered
12.18.5 Hikma Recent Development
12.19 Prinston
12.19.1 Prinston Corporation Information
12.19.2 Prinston Description and Business Overview
12.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Prinston Products Offered
12.19.5 Prinston Recent Development
12.20 Accord Hlthcare
12.20.1 Accord Hlthcare Corporation Information
12.20.2 Accord Hlthcare Description and Business Overview
12.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Accord Hlthcare Products Offered
12.20.5 Accord Hlthcare Recent Development
12.21 CASI Pharms
12.21.1 CASI Pharms Corporation Information
12.21.2 CASI Pharms Description and Business Overview
12.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.21.4 CASI Pharms Products Offered
12.21.5 CASI Pharms Recent Development
12.22 Invagen Pharms
12.22.1 Invagen Pharms Corporation Information
12.22.2 Invagen Pharms Description and Business Overview
12.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Invagen Pharms Products Offered
12.22.5 Invagen Pharms Recent Development
12.23 SUN Pharm
12.23.1 SUN Pharm Corporation Information
12.23.2 SUN Pharm Description and Business Overview
12.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2016-2021)
12.23.4 SUN Pharm Products Offered
12.23.5 SUN Pharm Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Lisinopril Industry Trends
13.2 Lisinopril Market Drivers
13.3 Lisinopril Market Challenges
13.4 Lisinopril Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Lisinopril Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Lisinopril Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 2.5mg
Table 3. Major Manufacturers of 5mg
Table 4. Major Manufacturers of 10mg
Table 5. Major Manufacturers of 20mg
Table 6. Major Manufacturers of 30mg
Table 7. Major Manufacturers of 40mg
Table 8. Global Lisinopril Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 9. Global Lisinopril Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Lisinopril Sales by Regions (2016-2021) & (K Units)
Table 11. Global Lisinopril Sales Market Share by Regions (2016-2021)
Table 12. Global Lisinopril Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Lisinopril Sales Forecast by Region (2022-2027) & (K Units)
Table 14. Global Lisinopril Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Lisinopril Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Lisinopril Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Lisinopril Sales by Manufacturers (2016-2021) (K Units)
Table 18. Global Lisinopril Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Lisinopril Manufacturers by Revenue (US$ Million) in 2020
Table 20. Lisinopril Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Lisinopril Revenue Share by Manufacturers (2016-2021)
Table 22. Global Lisinopril Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Lisinopril by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lisinopril as of 2020)
Table 24. Key Manufacturers Lisinopril Price (2016-2021) (US$/Unit)
Table 25. Lisinopril Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Lisinopril Product Type
Table 27. Date of International Manufacturers Enter into Lisinopril Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Lisinopril Sales by Type (2016-2021) (K Units)
Table 30. Global Lisinopril Sales Share by Type (2016-2021)
Table 31. Global Lisinopril Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Lisinopril Revenue Share by Type (2016-2021)
Table 33. Lisinopril Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 34. Global Lisinopril Sales Forecast by Type (2022-2027) & (K Units)
Table 35. Global Lisinopril Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Lisinopril Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Lisinopril Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Lisinopril Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 39. Global Lisinopril Sales by Application (2016-2021) (K Units)
Table 40. Global Lisinopril Sales Share by Application (2016-2021)
Table 41. Global Lisinopril Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Lisinopril Revenue Share by Application (2016-2021)
Table 43. Lisinopril Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 44. Global Lisinopril Sales Forecast by Application (2022-2027) & (K Units)
Table 45. Global Lisinopril Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Lisinopril Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Lisinopril Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Lisinopril Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 49. China Lisinopril Sales (K Units) of Key Companies (2016-2021)
Table 50. China Lisinopril Sales Share by Company (2016-2021)
Table 51. China Lisinopril Revenue (US$ Million) by Company (2016-2021)
Table 52. China Lisinopril Revenue Share by Company (2016-2021)
Table 53. China Lisinopril Sales (K Units) by Type (2016-2021)
Table 54. China Lisinopril Sales Share by Type (2016-2021)
Table 55. China Lisinopril Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Lisinopril Price (US$/Unit) by Type (2016-2021)
Table 57. China Lisinopril Sales (K Units) by Type (2022-2027)
Table 58. China Lisinopril Sales Share by Type (2022-2027)
Table 59. China Lisinopril Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Lisinopril Revenue Share by Type (2022-2027)
Table 61. China Lisinopril Price (US$/Unit) by Type (2022-2027)
Table 62. China Lisinopril Sales (K Units) by Application (2016-2021)
Table 63. China Lisinopril Sales Share by Application (2016-2021)
Table 64. China Lisinopril Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Lisinopril Price (US$/Unit) by Application (2016-2021)
Table 66. China Lisinopril Sales (K Units) by Application (2022-2027)
Table 67. China Lisinopril Sales Share by Application (2022-2027)
Table 68. China Lisinopril Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Lisinopril Revenue Share by Application (2022-2027)
Table 70. China Lisinopril Price (US$/Unit) by Application (2022-2027)
Table 71. North America Lisinopril Sales by Country (2016-2021) & (K Units)
Table 72. North America Lisinopril Sales Market Share by Country (2016-2021)
Table 73. North America Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Lisinopril Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Lisinopril Sales by Region (2016-2021) & (K Units)
Table 76. Asia Pacific Lisinopril Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Lisinopril Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Lisinopril Revenue Market Share by Region (2016-2021)
Table 79. Europe Lisinopril Sales by Country (2016-2021) & (K Units)
Table 80. Europe Lisinopril Sales Market Share by Country (2016-2021)
Table 81. Europe Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Lisinopril Revenue Market Share by Country (2016-2021)
Table 83. Latin America Lisinopril Sales by Country (2016-2021) & (K Units)
Table 84. Latin America Lisinopril Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Lisinopril Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Lisinopril Sales by Country (2016-2021) & (K Units)
Table 88. Middle East and Africa Lisinopril Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Lisinopril Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Lisinopril Revenue Market Share by Country (2016-2021)
Table 91. Actavis Elizabeth Corporation Information
Table 92. Actavis Elizabeth Description and Business Overview
Table 93. Actavis Elizabeth Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 94. Actavis Elizabeth Lisinopril Product
Table 95. Actavis Elizabeth Recent Development
Table 96. Apotex Corporation Information
Table 97. Apotex Description and Business Overview
Table 98. Apotex Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 99. Apotex Product
Table 100. Apotex Recent Development
Table 101. Aurobindo Pharma Corporation Information
Table 102. Aurobindo Pharma Description and Business Overview
Table 103. Aurobindo Pharma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 104. Aurobindo Pharma Product
Table 105. Aurobindo Pharma Recent Development
Table 106. Ivax Pharmaceuticals Corporation Information
Table 107. Ivax Pharmaceuticals Description and Business Overview
Table 108. Ivax Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. Ivax Pharmaceuticals Product
Table 110. Ivax Pharmaceuticals Recent Development
Table 111. Lek Pharmaceuticals Corporation Information
Table 112. Lek Pharmaceuticals Description and Business Overview
Table 113. Lek Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Lek Pharmaceuticals Product
Table 115. Lek Pharmaceuticals Recent Development
Table 116. Lupin Corporation Information
Table 117. Lupin Description and Business Overview
Table 118. Lupin Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Lupin Product
Table 120. Lupin Recent Development
Table 121. Mylan Pharmaceuticals Corporation Information
Table 122. Mylan Pharmaceuticals Description and Business Overview
Table 123. Mylan Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Mylan Pharmaceuticals Product
Table 125. Mylan Pharmaceuticals Recent Development
Table 126. Ranbaxy Pharmaceuticals Corporation Information
Table 127. Ranbaxy Pharmaceuticals Description and Business Overview
Table 128. Ranbaxy Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Ranbaxy Pharmaceuticals Product
Table 130. Ranbaxy Pharmaceuticals Recent Development
Table 131. Novartis Corporation Information
Table 132. Novartis Description and Business Overview
Table 133. Novartis Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Novartis Product
Table 135. Novartis Recent Development
Table 136. Teva Pharmaceuticals Corporation Information
Table 137. Teva Pharmaceuticals Description and Business Overview
Table 138. Teva Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Teva Pharmaceuticals Product
Table 140. Teva Pharmaceuticals Recent Development
Table 141. Vintage Pharmaceuticals Corporation Information
Table 142. Vintage Pharmaceuticals Description and Business Overview
Table 143. Vintage Pharmaceuticals Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Vintage Pharmaceuticals Product
Table 145. Vintage Pharmaceuticals Recent Development
Table 146. Watson Laboratories Corporation Information
Table 147. Watson Laboratories Description and Business Overview
Table 148. Watson Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Watson Laboratories Product
Table 150. Watson Laboratories Recent Development
Table 151. West Ward Pharmaceutical Corporation Information
Table 152. West Ward Pharmaceutical Description and Business Overview
Table 153. West Ward Pharmaceutical Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. West Ward Pharmaceutical Product
Table 155. West Ward Pharmaceutical Recent Development
Table 156. Wockhardt Corporation Information
Table 157. Wockhardt Description and Business Overview
Table 158. Wockhardt Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. Wockhardt Product
Table 160. Wockhardt Recent Development
Table 161. Merck Research Laboratories Corporation Information
Table 162. Merck Research Laboratories Description and Business Overview
Table 163. Merck Research Laboratories Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. Merck Research Laboratories Product
Table 165. Merck Research Laboratories Recent Development
Table 166. Astrazeneca Corporation Information
Table 167. Astrazeneca Description and Business Overview
Table 168. Astrazeneca Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 169. Astrazeneca Product
Table 170. Astrazeneca Recent Development
Table 171. Alvogen Corporation Information
Table 172. Alvogen Description and Business Overview
Table 173. Alvogen Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 174. Alvogen Product
Table 175. Alvogen Recent Development
Table 176. Hikma Corporation Information
Table 177. Hikma Description and Business Overview
Table 178. Hikma Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 179. Hikma Product
Table 180. Hikma Recent Development
Table 181. Prinston Corporation Information
Table 182. Prinston Description and Business Overview
Table 183. Prinston Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 184. Prinston Product
Table 185. Prinston Recent Development
Table 186. Accord Hlthcare Corporation Information
Table 187. Accord Hlthcare Description and Business Overview
Table 188. Accord Hlthcare Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 189. Accord Hlthcare Product
Table 190. Accord Hlthcare Recent Development
Table 191. CASI Pharms Corporation Information
Table 192. CASI Pharms Description and Business Overview
Table 193. CASI Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 194. CASI Pharms Product
Table 195. CASI Pharms Recent Development
Table 196. Invagen Pharms Corporation Information
Table 197. Invagen Pharms Description and Business Overview
Table 198. Invagen Pharms Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 199. Invagen Pharms Product
Table 200. Invagen Pharms Recent Development
Table 201. SUN Pharm Corporation Information
Table 202. SUN Pharm Description and Business Overview
Table 203. SUN Pharm Lisinopril Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 204. SUN Pharm Product
Table 205. SUN Pharm Recent Development
Table 206. Lisinopril Market Trends
Table 207. Lisinopril Market Drivers
Table 208. Lisinopril Market Challenges
Table 209. Lisinopril Market Restraints
Table 210. Lisinopril Customers List
Table 211. Lisinopril Distributors List
Table 212. Research Programs/Design for This Report
Table 213. Key Data Information from Secondary Sources
Table 214. Key Data Information from Primary Sources
List of Figures
Figure 1. Lisinopril Product Picture
Figure 2. Global Lisinopril Sales Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 20mg Product Picture
Figure 7. 30mg Product Picture
Figure 8. 40mg Product Picture
Figure 9. Global Lisinopril Sales Market Share by Application in 2020 & 2027
Figure 10. Hospital
Figure 11. Drug Store
Figure 12. Lisinopril Report Years Considered
Figure 13. Global Lisinopril Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Lisinopril Market Size 2016-2027 (US$ Million)
Figure 15. Global Lisinopril Sales 2016-2027 (K Units)
Figure 16. Global Lisinopril Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Lisinopril Sales Market Share by Region (2016-2021)
Figure 18. Global Lisinopril Sales Market Share by Region in 2020
Figure 19. Global Lisinopril Revenue Market Share by Region (2016-2021)
Figure 20. Global Lisinopril Revenue Market Share by Region in 2020
Figure 21. Global Lisinopril Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Lisinopril Revenue in 2020
Figure 23. Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Lisinopril Sales Market Share by Type (2016-2021)
Figure 25. Global Lisinopril Sales Market Share by Type in 2020
Figure 26. Global Lisinopril Revenue Market Share by Type (2016-2021)
Figure 27. Global Lisinopril Revenue Market Share by Type in 2020
Figure 28. Global Lisi
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs